irmukin-osimertinib-genvio

Osimertinib Mesylate – Irmukin

Osimertinib Mesylate synonym AZD9291 is a tyrosine kinase inhibitor (TKI) indicated for the patient with advanced metastatic non-small cell lung cancer or NSCLC. Irmukin is the brand name for Osimertinib Mesylate, a generic of Tagrisso by AstraZeneca, which is manufactured by Genvio Pharma Limited in Bangladesh. Genvio Pharma Limited is a renowned pharmaceutical company in Bangladesh manufacturing anti-cancer generics in affordable price by maintaining highest quality followed by cGMP guideline. Lung cancer has become one of the most prevalent cancer worldwide. Being one of the top anti-cancer medicine manufacturers in Bangladesh, Genvio Pharma is committed to manufacture better alternatives of research molecules at an affordable price. So Genvio keeps the price of Irmukin comparatively lower than the price of Tagrisso for the patients who cannot afford the costly treatment.

Irmukin as Osimertinib Mesylate synonym AZD9291 is available in 80 mg tablet in 30’s pack. Tagrisso generics Irmukin should be administered orally and can be taken with or without food, dosing 80 mg once daily. Each box of Irmukin contains patient medication information. So before starting medication please go through the leaflet on Irmukin website. You may also download this from Genvio website. The most common side effects of Irmukin as a Generic of Tagrisso by AstraZeneca can be nausea, cough, diarrhea, headache, fatigue etc. 

Irmukin is a low cost generic of Osimertinib Mesylate synonym AZD9291 which is a tyrosine kinase inhibitor (TKI) for the patient with advanced metastatic non-small cell lung cancer (NSCLC) that have a certain abnormal Epidermal Growth Factor Receptor (EGFR) gene mutation that has either spread to other parts of their body or not, and who have taken the medicine or chemotherapy before or completely treatment naive. Irmukin as Osimertinib Mesylate synonym AZD9291 is also only treatment option for patient with T790M positive in tumor specimen advanced non-small cell lung cancer or NSCLC.

Hence, Genvio Pharma Limited one of the top manufacturer for anti-cancer medicine in Bangladesh. Genvio is committed to manufacture quality medicine to fight EGFRm Positive and T790M positive lung cancer and convey it to the patient at a very low cost.